Actualités 11 out 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
News 18 out 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 26 jan 2022 Basel Area – exactly the right chemistry for South Korean pharma companies KPBMA and Basel Area Business & Innovation establish tailored collaboration to support Korean biopharmaceutical companies to enter the Europe...
Actualités 26 out 2022 Le fabricant chinois de vaccins CanSino Biologics s’installe à Genève pour lancer son vaccin Covid inhalé Ce premier vaccin Covid inhalé a été approuvé par les autorités chinoises il y a un mois. Cette technologie a également le potentiel de protéger ...
News 26 mai 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News 20 mai 2022 BeiGene opens European headquarters in Basel BeiGene has opened its new European headquarters in Basel. The global biotech company specializing in innovative cancer treatments intends to bui...
Actualités 13 set 2021 Incyte inaugure sa nouvelle usine de production à Yverdon Après avoir installé en 2020 son siège européen à Morges, le groupe biopharmaceutique américain Incyte renforce sa présence dans le canton de Vau...
News 26 out 2022 Chinese vaccine manufacturer CanSino Biologics sets up shop in Geneva to launch its inhaled Covid vaccine This first inhaled Covid vaccine against was approved by Chinese authorities a month ago. This technology has the potential to protect against ot...
Success stories 09 jun 2022 La Svizzera offre condizioni interessanti e stabili per le aziende internazionali Merck Il leader scientifico e tecnologico Merck è presente in Svizzera da quasi un secolo. Oggi ha otto sedi, tra cui cinque impianti di produzione, e ...
S-GE イベント オンラインセミナー 「スイスと欧州から実現させるサーキュラーエコノミー」 / Circular Economy Realization for Japanese Companies through the Performance of Switzerland and Europe
News 31 jul 2020 Basel gains new biotech in Bright Peak Versant Ventures has made a US$35 million Series A funding commitment to Bright Peak Therapeutics and has now announced the debut of this biotech...
News 10 jan 2020 Sotio opens office in Basel The Czech biotech company Sotio has opened an office in the Technologiepark Basel. Sotio Biotech AG will be responsible for the company’s clinica...
Aktuell 31 jul 2020 Basel bekommt mit Bright Peak neue Biotechfirma Versant Ventures hat Bright Peak Therapeutics eine Serie-A-Finanzierung von 35 Millionen Dollar zugesagt und jetzt die Gründung der Biotechfirma ...
Aktuell 10 jan 2020 Sotio siedelt sich in Basel an Die tschechische Biotechfirma Sotio hat eine Niederlassung im Technologiepark Basel gegründet. Die Sotio Biotech AG wird dort für die klinische E...
Aktuell 20 mai 2022 BeiGene eröffnet Europasitz in Basel BeiGene eröffnet in Basel seinen europäischen Hauptsitz. Die auf innovative Krebstherapien spezialisierte globale Biotechnologiefirma will von Ba...
Report 27 ago 2021 スイスの循環型経済 現在の直線型経済モデルは「take-make-waste」の原則に支配されています。その結果、生態系や天然資源への圧力が増しています。直線型経済モデルは、資源不足や資源の浪費を生み、最後には気候変動や生物多様性損失などの環境危機が生じます。人類は地球の限界(プラネタリー・バウンダリー)を超...